Inventor · disambiguated record
Xiaowu Liang
Also filed as: LIANG XIAOWU
13 granted patents·13 pending applications·411 citations·filing 1996–2017
93Inventor score
Top patents by PatentIndex Score
26 records- 0196US7927818B2Compositions and methods for immunodominant antigens of Mycobacterium tuberculosisFELGNER PHILIP·Filed 2009·Granted Apr 19, 2011·17 cites·13 claims
- 0295US5846946ACompositions and methods for administering Borrelia DNAPASTEUR MERIEUX SERUMS VACC·Filed 1996·Granted Dec 8, 1998·213 cites·18 claims
- 0392US9494586B2Compositions and methods for immunodominant antigens of Mycobacterium tuberculosisIMMPORT THERAPEUTICS INC·Filed 2014·Granted Nov 15, 2016·6 cites·13 claims
- 0492US8329418B2Compositions and methods for immunodominant antigens of Mycobacterium tuberculosisFELGNER PHILIP·Filed 2012·Granted Dec 11, 2012·6 cites·13 claims
- 0591US6280977B1Method for generating transcriptionally active DNA fragmentsGENE THERAPY SYSTEMS·Filed 2000·Granted Aug 28, 2001·48 cites·12 claims
- 0689US8883431B2Compositions and methods for immunodominant antigens of Mycobacterium tuberculosisFELGNER PHILIP·Filed 2012·Granted Nov 11, 2014·4 cites·12 claims
- 0789US8114614B2Compositions and methods for immunodominant antigens of Mycobacterium tuberculosisFELGNER PHILIP·Filed 2011·Granted Feb 14, 2012·8 cites·13 claims
- 0889US6936470B2Rapid and enzymeless cloning of nucleic acid fragmentsGENE THERAPY SYSTEMS INC·Filed 2002·Granted Aug 30, 2005·27 cites·86 claims
- 0981US6451769B1Compositions and methods for administering Borrelia DNAPASTEUR MERIEUX SERUMS VACC·Filed 1998·Granted Sep 17, 2002·49 cites·12 claims
- 1075US9297803B2Compositions and methods for immunodominant antigensFELGNER PHILIP·Filed 2007·Granted Mar 29, 2016·0 cites·6 claims
- 1173US5891718ATetracycline inducible/repressible systemsVICAL INC·Filed 1996·Granted Apr 6, 1999·33 cites·16 claims
- 1273US2015056241A1Compositions And Methods For Immunodominant AntigensIMMPORT THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1368US10174311B2Compositions and methods for immunodominant antigensIMMPORT THERAPEUTICS INC·Filed 2016·Granted Jan 8, 2019·0 cites·14 claims
- 1467US10053687B2Compositions and methods for immunodominant antigens of Mycobacterium tuberculosisIMMPORT THERAPEUTICS INC·Filed 2016·Granted Aug 21, 2018·0 cites·13 claims
- 1558US2006240469A1Method for generating transcriptionally active DNA fragmentsLIANG XIAOWU·Filed 2006·Application pending·0 cites
- 1657US2002037525A1Method for generating transcriptionally active DNA fragmentsFiled 2001·Application pending·0 cites
- 1754US2018045735A1Methods and Compositions For The Diagnosis And Treatment Of Cancer and Autoimmune DisordersIMMPORT THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1850US2005233422A1Rapid and enzymeless cloning of nucleic acid fragmentsLIANG XIAOWU·Filed 2005·Application pending·0 cites
- 1950US2002165175A1Fast and enzymeless cloning of nucleic acid fragmentsFiled 2001·Application pending·0 cites
- 2049US2015037367A1Methods and Compositions Of Protein Antigens For The Diagnosis And Treatment of Herpes Simplex Viruses Type 1 and 2DAVIES DAVID HUW·Filed 2012·Application pending·0 cites
- 2149US2013310266A1Methods and Compositions For The Diagnosis And Treatment Of Cancer and Autoimmune DisordersLIANG XIAOWU·Filed 2011·Application pending·0 cites
- 2247US2008260763A1High Throughput ProteomicsUNIV CALIFORNIA·Filed 2005·Application pending·0 cites
- 2344US2015313982A1Methods and compositions of protein antigens for the diagnosis and treatment of leptospirosisUNIV CALIFORNIA·Filed 2013·Application pending·0 cites
- 2443US2016158344A1Methods And Compositions of Protein Antigens For The Diagnosis And Treatment of Herpes Simplex Viruses Type 1 And 2IMMPORT THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2542US2014004141A1Methods And Compositions Of Protein Antigens For The Diagnosis And Treatment Of Toxoplasma Gondii Infections And ToxoplasmosisDAVIES DAVID HUW·Filed 2011·Application pending·0 cites
- 2640US2014348870A1Immunogenic plasmodium falciparum antigen compositions and uses thereofUNIV CALIFORNIA·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →